출판 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2023년05월
헬스케어 시장에서의 메타버스(Metaverse in Healthcare) : 구성 요소(하드웨어, 서비스, 소프트웨어), 기술(AR/VR, MR, AI, 블록체인, IoT), 용도(원격 의료, 진단, 의료 교육 및 교육), 최종 사용자(의료 제공자, 환자, 지불자) , 제약 회사) – 2028 년까지 세계 예측
Metaverse in Healthcare Market by Component (Hardware, Services, Software), Technology (AR/VR, MR, AI, Blockchain, IoT), Application(Telehealth, Diagnostics, Medical Training & Education), End User (Provider, Patients, Payers, Pharma) – Global Forecast to 2028
페이지수 | 233 |
도표수 | 160 |
구성 | 영문조사보고서 |
가격 |
The global metaverse in healthcare market is projected to reach USD 79.6 billion by 2028 from USD 9.5 billion in 2023, at a CAGR of 52.9% during the forecast period. There is a growing inclination for metaverse technologies for healthcare in North America.
헬스케어 시장의 글로벌 메타버스는 2023년 95억 달러에서 예측 기간 동안 연평균 52.9% 성장하여 2028년 796억 달러에 이를 것으로 예상됩니다. 북미 지역의 의료용 메타버스 기술에 대한 경향이 커지고 있습니다.
Increasing popularity of virtual and augmented reality (VR/AR) technologies, which have been used in various healthcare applications, including surgical training, pain management, and therapy is attributing to growth of the market in this region. In addition, the COVID-19 pandemic has accelerated the adoption of telehealth services, which has created a need for more immersive and engaging virtual experiences for patients and healthcare providers. The metaverse can provide a virtual environment that simulates real-life interactions, allowing patients and healthcare professionals to communicate and collaborate in a more natural and intuitive way.
주요 대상 세그먼트
- 컴포넌트
- 소프트웨어
- 하드웨어
- 증강 현실(AR) 기기
- 가상 현실(VR) 기기
- 복합 현실(MR) 기기
- 디스플레이
- 서비스
- 기술
- 증강 현실/가상 현실(가상 현실)
- 복합 현실
- 인공지능
- 블록체인
- 디지털 트윈
- IoT
- 의료 웨어러블 기기
- 용도
- 디지털 치료(DTx)
- 의학적 진단
- 원격 의료 – 텔레헬스 및 텔레메디슨
- 의학 교육
- 드래그 전달 및 개인화 의료
- 기타 사용
- 최종 사용자
- 의료 제공자
- 지불자
- 환자
- 제약 회사 및 바이오 의약품 메도텍(MedTech) 기업
- 지역
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 영국
- 기타 유럽
- 아시아 태평양 지역
- 일본
- 중국
- 기타 아시아 태평양 지역
- 라틴 아메리카
- 중동 및 아프리카
- 북미
“The software segment is projected to be the largest segment in the metaverse in healthcare market”.
Based on the components, the software segment is projected to be the largest segment during the forecast period. This share can be attributed to factors such as potential for customization and personalization. Healthcare professionals and patients can use software to create and access virtual environments that are tailored to their specific needs, preferences, and medical conditions, increasing adaptation of AR platforms to perform complex surgical procedures for higher precision and flexibility and investments made in the software segment.
“Healthcare Provider was the largest segment by the end user of metaverse in healthcare market in 2022”.
Healthcare provider is projected to grow at the highest growth rate in the metaverse in healthcare market in 2022. The high growth can be attributed to rising need for an efficient healthcare system, growing patient volume, increasing number of hospitals and ambulatory care centers, growth in telehealth and rising adoption of metaverse technology in healthcare.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors owing to the growing medical tourism industry, increasing incidence of lifestyle and chronic disorders, and the rising adoption of metaverse technologies. Asia Pacific market offer lucrative growth opportunities for market players, mainly due to the growing government initiatives and the increasing incidence of lifestyle disorders. The growth in these markets will likely be centered in China, South Korea, and Japan. This is mainly due to the rising need for advanced healthcare technology to track and monitor the huge volume of patients, and the rising demand for quality healthcare at low costs are driving the growth of this market.
The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
• By Designation – C-level: 31%, Director-level: 27%, and Others: 42%
• By Region – North America: 40%, Europe: 20%, Asia Pacific: 30%, Latin America: 5%, and Middle East & Africa: 5%.
Key players in the Metaverse in Healthcare Market
The key players operating in the metaverse in healthcare market include Microsoft (US), NVIDIA Corporation (US), XRHealth (US), CAE, Inc.(Canada), Koninklijke Philips N.V. (Netherlands), ImmersiveTouch, Inc. (US), Wipro (India), Siemens Healthineers AG (Germany), Medtronic plc(Ireland), GE Healthcare(US), Intuitive Surgical (US), 8Chili, Inc. (US), MindMaze (Switzerland), AccuVein, Inc.(US),EON Reality(US), Brainlab AG (Germany), Novarad Corporation (US), Oodles Technologies (India), CMR Surgical(UK), Merative (US), BioflightVR(US), WorldViz, Inc. (US), Google(US), Oculus(Meta Platforms, Inc.)(US), Augmedics(US)
Research Coverage:
The report analyses the metaverse in healthcare market and aims to estimate the market size and future growth potential of various market segments, based on components, application, technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market.
The report provides insights on the following pointers:
• Analysis of key drivers (Increasing adoption of mixed reality for performing minimally invasive surgeries, Applications of metaverse in telemedicine, Increasing use of digital twins, Increasing importance of blockchain technology in healthcare) restraints (Data privacy and security concerns, High implementation cost, Health and mental issues from excessive use), opportunities (increasing use of metaverse in medical education and training and use of metaverse in surgical applications) and challenges ( HIPAA regulations for healthcare metaverse, Interoperability issues, Local government restrictions coupled with environmental impact)
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the metaverse in healthcare market
• Market Development: Comprehensive information about lucrative markets – the report analyses the metaverse in healthcare market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the metaverse in healthcare market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Microsoft (US), NVIDIA Corporation (US), XRHealth (US), CAE, Inc.(Canada), Koninklijke Philips N.V. (Netherlands), ImmersiveTouch, Inc. (US), Wipro (India), Siemens Healthineers AG (Germany), Medtronic plc(Ireland), GE Healthcare(US), Intuitive Surgical (US), 8Chili, Inc. (US), MindMaze (Switzerland), AccuVein, Inc.(US),EON Reality(US), Brainlab AG (Germany), Novarad Corporation (US), Oodles Technologies (India), among others in the metaverse in healthcare market strategies. The report also helps stakeholders understand the pulse of the remote care market and provides them information on key market drivers, restraints, challenges, and opportunities.
목차
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.3 MARKETS COVERED 27
1.3.1 METAVERSE IN HEALTHCARE MARKET SEGMENTATION, BY REGION 28
1.3.2 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
1.5 STAKEHOLDERS 29
1.6 LIMITATIONS 29
1.7 RECESSION IMPACT 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH APPROACH 30
2.2 RESEARCH METHODOLOGY DESIGN 30
FIGURE 1 METAVERSE IN HEALTHCARE MARKET: RESEARCH DESIGN 30
2.2.1 SECONDARY RESEARCH 31
2.2.1.1 Key data from secondary sources 32
2.2.2 PRIMARY DATA 32
FIGURE 2 PRIMARY SOURCES 32
2.2.2.1 Key data from primary sources 33
2.2.2.2 Insights from primary experts 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION 34
2.3 MARKET SIZE ESTIMATION: METAVERSE IN HEALTHCARE MARKET 35
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35
FIGURE 5 METAVERSE IN HEALTHCARE MARKET: TOP-DOWN AND BOTTOM-UP APPROACHES 36
2.3.1 DEMAND-SIDE APPROACH 37
FIGURE 6 MARKET PROJECTIONS FROM DEMAND-SIDE 37
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 40
2.5 MARKET RANKING ESTIMATION 41
2.6 ASSUMPTIONS 41
2.7 LIMITATIONS 42
2.7.1 METHODOLOGY-RELATED LIMITATIONS 42
2.7.2 SCOPE-RELATED LIMITATIONS 42
2.8 RISK ASSESSMENT 42
TABLE 1 RISK ASSESSMENT: METAVERSE IN HEALTHCARE MARKET 42
2.9 IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 42
3 EXECUTIVE SUMMARY 44
FIGURE 2 METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 44
FIGURE 3 METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 45
FIGURE 4 METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46
FIGURE 5 METAVERSE IN HEALTHCARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 46
FIGURE 6 GEOGRAPHICAL SNAPSHOT OF METAVERSE IN HEALTHCARE MARKET 47
4 PREMIUM INSIGHTS 49
4.1 METAVERSE IN HEALTHCARE MARKET OVERVIEW 49
FIGURE 7 INCREASING ADOPTION OF MIXED REALITY SOLUTIONS IN HEALTHCARE APPLICATIONS TO DRIVE MARKET GROWTH 49
4.2 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT AND COUNTRY 50
FIGURE 8 SOFTWARE SEGMENT TO COMMAND LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023 50
4.3 GEOGRAPHICAL SNAPSHOT OF METAVERSE IN HEALTHCARE MARKET 51
FIGURE 9 MARKET IN CHINA TO GROW AT HIGHEST CAGR 51
4.4 REGIONAL MIX: METAVERSE IN HEALTHCARE MARKET 52
FIGURE 10 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 52
4.5 METAVERSE IN HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING MARKETS 52
FIGURE 11 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
TABLE 2 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing adoption of mixed reality for performing minimally invasive surgeries 54
5.2.1.2 Applications of metaverse in telemedicine 54
5.2.1.3 Increasing use of digital twins 55
5.2.1.4 Increasing importance of blockchain technology in healthcare 56
5.2.2 RESTRAINTS 57
5.2.2.1 Data privacy and security concerns 57
FIGURE 12 US: NUMBER OF DATA BREACHES (2005–2022) 58
5.2.2.2 High implementation cost 58
5.2.2.3 Health and mental issues from excessive use 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Increasing use of metaverse in medical education and training 59
5.2.3.2 Use of metaverse in surgical applications 60
5.2.4 CHALLENGES 60
5.2.4.1 HIPAA regulations for healthcare metaverse 60
5.2.4.2 Interoperability issues 61
5.2.4.3 Local government restrictions coupled with environmental impact 61
6 INDUSTRY INSIGHTS 62
6.1 INDUSTRY TRENDS 62
6.1.1 TRANSFORMATION IN CLINICAL TRIALS 62
6.1.2 EMERGENCE OF IMMERSIVE THERAPEUTICS 62
6.1.3 FUTURE TRENDS IN METAVERSE IN HEALTHCARE 62
6.2 RISE IN HEALTHCARE METAVERSE INVESTMENTS 63
6.3 TECHNOLOGY ANALYSIS 64
6.3.1 TECHNOLOGY STACK 64
FIGURE 13 METAVERSE MARKET: TECHNOLOGIES 64
6.3.2 INFRASTRUCTURE LEVEL 64
6.3.2.1 5G network 64
6.3.2.2 Internet of Things 65
6.3.2.3 Cloud and edge computing 65
6.3.3 DESIGN AND DEVELOPMENT LEVEL 65
6.3.3.1 Blockchain 65
6.3.3.2 3D modeling and real-time rendering 65
6.3.3.3 Artificial intelligence, natural language processing, and computer vision 66
6.3.4 HUMAN INTERACTION LEVEL 66
6.3.4.1 Virtual reality 66
6.3.4.2 Augmented reality 66
6.3.4.2.1 Monitor-based AR technology 67
6.3.4.2.2 Near-eye-based AR technology 67
6.3.4.2.3 Web AR 68
6.3.4.3 Mixed reality 68
6.4 PORTER’S FIVE FORCES ANALYSIS 68
FIGURE 14 METAVERSE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 69
TABLE 3 METAVERSE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 69
6.4.1 INTENSITY OF COMPETITIVE RIVALRY 70
6.4.2 BARGAINING POWER OF SUPPLIERS 70
6.4.3 BARGAINING POWER OF BUYERS 70
6.4.4 THREAT OF NEW ENTRANTS 71
6.4.5 THREAT OF SUBSTITUTES 71
6.5 REGULATORY LANDSCAPE 72
6.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
6.5.2 REGULATORY IMPLICATIONS AND INDUSTRY STANDARDS 77
6.6 VALUE-CHAIN ANALYSIS 77
FIGURE 15 VALUE-CHAIN ANALYSIS (2022) 78
6.7 ECOSYSTEM 78
FIGURE 16 METAVERSE IN HEALTHCARE MARKET: ECOSYSTEM 79
6.8 PATENT ANALYSIS 79
FIGURE 17 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO MARCH 2023 79
FIGURE 18 TOP METAVERSE IN HEALTHCARE PATENT OWNERS 80
TABLE 8 KEY PATENTS IN THE METAVERSE IN HEALTHCARE MARKET 80
6.9 CASE STUDY ANALYSIS 81
6.9.1 CASE STUDY 1: RIGOROUS TRAINING OF PROFESSIONAL ATHLETES WITHOUT PHYSICAL STRAIN 81
6.9.2 CASE STUDY 2: AUGMENTED REALITY FOR SURGERY 82
6.9.3 CASE STUDY 3: VIRTUAL HOSPITALS AND CLINICS 82
6.9.4 CASE STUDY 4: ENTERING DRUG DISCOVERY AND RESEARCH 82
6.9.5 CASE STUDY 5: ENTERING MEDICAL TRAINING AND EDUCATION 83
6.10 KEY STAKEHOLDERS AND BUYING CRITERIA 83
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 83
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 84
6.10.2 BUYING CRITERIA 84
FIGURE 20 KEY BUYING CRITERIA FOR METAVERSE COMPONENTS 84
TABLE 10 KEY BUYING CRITERIA FOR METAVERSE COMPONENTS 84
6.11 KEY CONFERENCES AND EVENTS IN 2023–2024 85
TABLE 11 METAVERSE IN HEALTHCARE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 85
6.12 TRENDS/DISRUPTIONS IMPACTING BUYERS 86
FIGURE 21 METAVERSE MARKET: TRENDS/DISRUPTIONS IMPACTING BUYERS 86
7 METAVERSE IN HEALTHCARE MARKET, BY COMPONENT 87
7.1 INTRODUCTION 88
TABLE 12 METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 88
TABLE 13 METAVERSE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
7.2 SOFTWARE 89
7.2.1 INCREASING INVESTMENTS IN AR/VR TECHNOLOGY IN HEALTHCARE TO DRIVE GROWTH 89
TABLE 14 METAVERSE IN HEALTHCARE SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
7.3 HARDWARE 90
7.3.1 AR DEVICES 90
7.3.2 VR DEVICES 91
7.3.3 MR DEVICES 91
7.3.4 DISPLAYS 91
TABLE 15 METAVERSE IN HEALTHCARE HARDWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
7.4 SERVICES 92
7.4.1 SERVICES HELP IMPROVE PATIENT CARE, ENHANCE MEDICAL TRAINING AND EDUCATION, AND ENABLE REMOTE HEALTHCARE 92
TABLE 16 METAVERSE IN HEALTHCARE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
8 METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY 94
8.1 INTRODUCTION 95
TABLE 17 METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 95
8.2 AUGMENTED AND VIRTUAL REALITY 95
8.2.1 INCREASING DEMAND FOR AR/VR APPLICATIONS IN HEALTHCARE TO DRIVE GROWTH 95
TABLE 18 METAVERSE IN HEALTHCARE MARKET FOR AUGMENTED AND VIRTUAL REALITY, BY COUNTRY, 2021–2028 (USD MILLION) 96
8.3 MIXED REALITY 96
8.3.1 INCREASING AWARENESS OF DIGITAL/VIRTUAL MEDICINE TO DRIVE GROWTH 96
TABLE 19 METAVERSE IN HEALTHCARE MARKET FOR MIXED REALITY, BY COUNTRY, 2021–2028 (USD MILLION) 97
8.4 ARTIFICIAL INTELLIGENCE 97
8.4.1 WIDE AVAILABILITY OF COMPLEX DATASETS TO DRIVE GROWTH 97
TABLE 20 METAVERSE IN HEALTHCARE MARKET FOR ARTIFICIAL INTELLIGENCE, BY COUNTRY, 2021–2028 (USD MILLION) 98
8.5 BLOCKCHAIN 98
8.5.1 INCREASING NEED TO REDUCE COST OF SECURE DATA EXCHANGE TO DRIVE GROWTH 98
TABLE 21 METAVERSE IN HEALTHCARE MARKET FOR BLOCKCHAIN, BY COUNTRY, 2021–2028 (USD MILLION) 99
8.6 DIGITAL TWIN 99
8.6.1 INCREASING ADOPTION OF DIGITALIZATION IN HEALTHCARE TO PROPEL MARKET GROWTH 99
TABLE 22 DESCRIPTION OF DIGITAL TWIN IN HEALTHCARE CONTEXT 100
TABLE 23 METAVERSE IN HEALTHCARE MARKET FOR DIGITAL TWIN, BY COUNTRY, 2021–2028 (USD MILLION) 100
8.7 INTERNET OF THINGS 100
8.7.1 ADVANCEMENTS IN HEALTHCARE AND WIDE ACCEPTANCE OF REMOTE CARE TO DRIVE GROWTH 100
TABLE 24 METAVERSE IN HEALTHCARE MARKET FOR INTERNET OF THINGS, BY COUNTRY, 2021–2028 (USD MILLION) 101
8.8 MEDICAL WEARABLES 102
8.8.1 INCREASING FOCUS ON FITNESS AND HEALTH TO SUPPORT GROWTH 102
TABLE 25 METAVERSE IN HEALTHCARE MARKET FOR MEDICAL WEARABLES, BY COUNTRY, 2021–2028 (USD MILLION) 102
9 METAVERSE IN HEALTHCARE MARKET, BY APPLICATION 103
9.1 INTRODUCTION 104
TABLE 26 METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
9.2 DIGITAL THERAPEUTICS 104
9.2.1 RISING INCIDENCE OF PREVENTABLE CHRONIC DISEASES TO DRIVE GROWTH 104
TABLE 27 METAVERSE IN HEALTHCARE MARKET FOR DIGITAL THERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION) 105
9.3 MEDICAL DIAGNOSTICS 105
9.3.1 METAVERSE ENVIRONMENT CAN OFFER ENHANCED MEDICAL DIAGNOSTICS 105
TABLE 28 METAVERSE IN HEALTHCARE MARKET FOR MEDICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 106
9.4 MEDICAL EDUCATION AND SURGICAL TRAINING 106
9.4.1 METAVERSE ADDING NEW DIMENSIONS TO MEDICAL EDUCATION AND SURGICAL TRAINING 106
TABLE 29 METAVERSE IN HEALTHCARE MARKET FOR MEDICAL EDUCATION AND SURGICAL TRAINING, BY COUNTRY, 2021–2028 (USD MILLION) 107
9.5 TELEHEALTH AND TELEMEDICINE 107
9.5.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET GROWTH 107
TABLE 30 METAVERSE IN HEALTHCARE MARKET FOR TELEHEALTH AND TELEMEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 108
9.6 DRUG DISCOVERY AND PERSONALIZED MEDICINE 109
9.6.1 METAVERSE TO HELP REDUCE TIME AND COST INVOLVED IN DRUG DISCOVERY 109
TABLE 31 METAVERSE IN HEALTHCARE MARKET FOR DRUG DISCOVERY AND PERSONALIZED MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 110
9.7 OTHER APPLICATIONS 110
TABLE 32 METAVERSE IN HEALTHCARE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111
10 METAVERSE IN HEALTHCARE MARKET, BY END USER 112
10.1 INTRODUCTION 113
TABLE 33 METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 113
10.2 HEALTHCARE PROVIDERS 113
10.2.1 INCREASING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST GROWTH 113
TABLE 34 METAVERSE IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 114
10.3 HEALTHCARE PAYERS 114
10.3.1 INCREASING FOCUS ON OUTCOME-BASED PAYMENT MODELS TO DRIVE DEMAND 114
TABLE 35 METAVERSE IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 115
10.4 PHARMACEUTICAL, BIOPHARMACEUTICAL, AND MEDTECH COMPANIES 115
10.4.1 ENHANCED CLINICAL TRIALS AND BETTER COLLABORATION AND COMMUNICATION TO DRIVE GROWTH 115
TABLE 36 METAVERSE IN HEALTHCARE MARKET FOR PHARMACEUTICAL, BIOPHARMACEUTICAL, AND MEDTECH COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 116
10.5 PATIENTS 117
10.5.1 INCREASED ACCESS TO CARE AND IMPROVED PATIENT OUTCOMES TO SUPPORT MARKET GROWTH 117
TABLE 37 METAVERSE IN HEALTHCARE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 117
10.6 OTHER END USERS 118
TABLE 38 METAVERSE IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 119
11 METAVERSE IN HEALTHCARE MARKET, BY REGION 120
11.1 INTRODUCTION 121
TABLE 39 METAVERSE IN HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 121
11.2 NORTH AMERICA 121
11.2.1 NORTH AMERICA: IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 121
FIGURE 22 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET SNAPSHOT 122
TABLE 40 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 41 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 123
TABLE 42 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124
TABLE 43 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
TABLE 44 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 125
11.2.2 US 125
11.2.2.1 Increasing adoption of healthcare technologies to drive growth 125
TABLE 45 US: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 125
TABLE 46 US: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
TABLE 47 US: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
TABLE 48 US: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 127
11.2.3 CANADA 127
11.2.3.1 Increasing focus on patient-centric care to support growth 127
TABLE 49 CANADA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 128
TABLE 50 CANADA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
TABLE 51 CANADA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 52 CANADA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 129
11.3 EUROPE 130
11.3.1 EUROPE: IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 130
TABLE 53 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 54 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 131
TABLE 55 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 131
TABLE 56 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 132
TABLE 57 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 132
11.3.2 UK 133
11.3.2.1 Recent technological advancements and focus on better patient outcomes to drive growth 133
TABLE 58 UK: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 133
TABLE 59 UK: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 134
TABLE 60 UK: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 61 UK: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 135
11.3.3 GERMANY 135
11.3.3.1 Increasing number of AR/VR start-ups to boost growth 135
TABLE 62 GERMANY: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 136
TABLE 63 GERMANY: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136
TABLE 64 GERMANY: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 65 GERMANY: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 137
11.3.4 REST OF EUROPE 137
TABLE 66 REST OF EUROPE: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 138
TABLE 67 REST OF EUROPE: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 138
TABLE 68 REST OF EUROPE: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 69 REST OF EUROPE: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 139
11.4 ASIA PACIFIC 140
11.4.1 ASIA PACIFIC: IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 140
FIGURE 23 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET SNAPSHOT 141
TABLE 70 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 71 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 142
TABLE 72 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143
TABLE 73 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 74 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 144
11.4.2 CHINA 144
11.4.2.1 Presence of large consumer base and increasing demand for quality healthcare to boost growth 144
TABLE 75 CHINA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 145
TABLE 76 CHINA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145
TABLE 77 CHINA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 78 CHINA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 146
11.4.3 JAPAN 146
11.4.3.1 Adoption of wireless technology and government support to drive growth 146
TABLE 79 JAPAN: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 147
TABLE 80 JAPAN: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 147
TABLE 81 JAPAN: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 82 JAPAN: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 148
11.4.4 REST OF ASIA PACIFIC 149
TABLE 83 REST OF ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 149
TABLE 84 REST OF ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 150
TABLE 85 REST OF ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 86 REST OF ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 151
11.5 LATIN AMERICA 151
11.5.1 LATIN AMERICA: IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 151
TABLE 87 LATIN AMERICA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 152
TABLE 88 LATIN AMERICA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 152
TABLE 89 LATIN AMERICA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 90 LATIN AMERICA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 153
11.6 MIDDLE EAST AND AFRICA 154
11.6.1 INVESTMENTS IN DIGITAL TECHNOLOGIES TO SUPPORT GROWTH 154
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT ON METAVERSE IN HEALTHCARE MARKET 154
TABLE 91 MIDDLE EAST & AFRICA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 155
TABLE 92 MIDDLE EAST & AFRICA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 155
TABLE 93 MIDDLE EAST & AFRICA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156
TABLE 94 MIDDLE EAST & AFRICA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 156
12 COMPETITIVE LANDSCAPE 157
12.1 OVERVIEW 157
12.2 KEY STRATEGIES/RIGHT TO WIN 157
TABLE 95 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN METAVERSE IN HEALTHCARE MARKET 157
FIGURE 24 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND MARCH 2023 160
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 161
FIGURE 25 METAVERSE IN HEALTHCARE MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS 161
12.4 METAVERSE IN HEALTHCARE MARKET: R&D EXPENDITURE 161
FIGURE 26 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022) 161
12.5 MARKET RANKING ANALYSIS 162
FIGURE 27 METAVERSE IN HEALTHCARE MARKET RANKING ANALYSIS OF KEY PLAYERS (2022) 162
12.6 COMPETITIVE BENCHMARKING 164
TABLE 96 FOOTPRINT OF COMPANIES IN METAVERSE IN HEALTHCARE MARKET 164
TABLE 97 PRODUCT/SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES) 165
TABLE 98 TECHNOLOGY FOOTPRINT OF COMPANIES (25 COMPANIES) 166
TABLE 99 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 167
12.7 COMPANY EVALUATION MATRIX 168
12.7.1 STARS 168
12.7.2 EMERGING LEADERS 168
12.7.3 PERVASIVE PLAYERS 168
12.7.4 PARTICIPANTS 168
FIGURE 28 METAVERSE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 169
12.8 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 169
12.8.1 PROGRESSIVE COMPANIES 169
12.8.2 DYNAMIC COMPANIES 170
12.8.3 RESPONSIVE COMPANIES 170
12.8.4 STARTING BLOCKS 170
FIGURE 29 METAVERSE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 170
12.9 COMPETITIVE SCENARIO 171
12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 171
TABLE 100 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020–MARCH 2023 171
12.9.2 DEALS 172
TABLE 101 DEALS, JANUARY 2020–MARCH 2023 172
13 COMPANY PROFILES 173
13.1 KEY PLAYERS 173
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 MICROSOFT 173
TABLE 102 MICROSOFT: BUSINESS OVERVIEW 173
FIGURE 30 MICROSOFT: COMPANY SNAPSHOT (2022) 174
13.1.2 NVIDIA CORPORATION 177
TABLE 103 NVIDIA CORPORATION: BUSINESS OVERVIEW 177
FIGURE 31 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022) 178
13.1.3 KONINKLIJKE PHILIPS N.V. 182
TABLE 104 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 182
FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 183
13.1.4 CAE INC. 186
TABLE 105 CAE INC.: BUSINESS OVERVIEW 186
FIGURE 33 CAE INC.: COMPANY SNAPSHOT (2022) 187
13.1.5 XRHEALTH 189
TABLE 106 XRHEALTH: BUSINESS OVERVIEW 189
13.1.6 IMMERSIVETOUCH, INC. 191
TABLE 107 IMMERSIVETOUCH, INC.: BUSINESS OVERVIEW 191
13.1.7 WIPRO 193
TABLE 108 WIPRO: BUSINESS OVERVIEW 193
FIGURE 34 WIPRO: COMPANY SNAPSHOT (2022) 194
13.1.8 SIEMENS HEALTHINEERS AG 196
TABLE 109 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 196
FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022) 197
13.1.9 MEDTRONIC PLC 199
TABLE 110 MEDTRONIC PLC: BUSINESS OVERVIEW 199
FIGURE 36 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 200
13.1.10 GE HEALTHCARE 202
TABLE 111 GE HEALTHCARE: BUSINESS OVERVIEW 202
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 203
13.1.11 INTUITIVE SURGICAL, INC. 205
TABLE 112 INTUITIVE SURGICAL, INC.: BUSINESS OVERVIEW 205
FIGURE 38 INTUITIVE SURGICAL, INC.: COMPANY SNAPSHOT (2022) 206
13.1.12 BRAINLAB AG 208
TABLE 113 BRAINLAB AG: BUSINESS OVERVIEW 208
13.1.13 NOVARAD CORPORATION 211
TABLE 114 NOVARAD CORPORATION: COMPANY OVERVIEW 211
13.1.14 OODLES TECHNOLOGIES 213
TABLE 115 OODLES TECHNOLOGIES: COMPANY OVERVIEW 213
13.1.15 CMR SURGICAL 214
TABLE 116 CMR SURGICAL: COMPANY OVERVIEW 214
13.1.16 MERATIVE 217
TABLE 117 MERATIVE: COMPANY OVERVIEW 217
13.1.17 WORLDVIZ, INC. 219
TABLE 118 WORLDVIZ, INC.: BUSINESS OVERVIEW 219
13.1.18 GOOGLE 220
TABLE 119 GOOGLE: BUSINESS OVERVIEW 220
FIGURE 39 GOOGLE: COMPANY SNAPSHOT (2022) 221
13.1.19 OCULUS (META PLATFORMS) 223
TABLE 120 OCULUS (META PLATFORMS): BUSINESS OVERVIEW 223
13.1.20 MINDMAZE 225
TABLE 121 MINDMAZE: BUSINESS OVERVIEW 225
13.2 OTHER PLAYERS 227
13.2.1 AUGMEDICS 227
13.2.2 ACCUVEIN, INC. 227
13.2.3 EON REALITY 228
13.2.4 BIOFLIGHTVR 228
13.2.5 8CHILI, INC. 229
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 230
14.1 DISCUSSION GUIDE 230
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 234
14.3 CUSTOMIZATION OPTIONS 236
14.4 RELATED REPORTS 236
14.5 AUTHOR DETAILS 237